Bio-Intervention Specialists (Bio-IS) announces that beginning in late November, it will provide nationwide on-site bio-intervention services for hospitals experiencing infectious disease challenges. These services will be based on a recently EPA-registered broad-spectrum hospital disinfectant, Electro-BioCide. Electro-BioCide is an EPA Category IV practically non-toxic, environmentally friendly disinfectant that also offers the broad-spectrum, six log kill that healthcare institutions seek.
Bio-IS hospital disinfection service focuses on improving the overall disinfection of a hospitals physical plant through an integrated Bio-Intervention Process. Combining the unique power of Electro-BioCide with a state-of-the-art electrostatic spraying system and certified bio-intervention personnel, Bio-IS is prepared to quickly respond on-site to any hospital in the United States. Bio-IS provides hospitals with a 21st Century technology solution to replace the spray bottle and rag that has been used for hard-surface disinfection for decades. Bio-Intervention specialist personnel can respond to emergent situations or can be positioned permanently at any hospital. The companys bio-intervention service solves the current weak links of hard-surface infection control.
Bio-IS understands the significant challenge that hospital-acquired infections represent to healthcare providers. Accounting for nearly 100,000 deaths per year in the U.S. and infecting an estimated 1.7 million people, hospital-acquired infections are widely recognized as a patient safety and economic challenge that must be addressed. Business Week recently recognized stopping infection in hospitals as one of the top five methods for controlling healthcare costs.
Despite attempts to decrease the prevalence of hospital-acquired infections, research shows that the problem continues to grow. In April, the Associated Press quoted Nancy Foster, vice president for quality and safety at the American Hospital Association, as saying, We are doing that which we know how to do, and its not having the intended effect. We need to identify other things we can do to drive down that rate of infections.
Infection control experts have identified the hospital environment as an important reservoir for infectious organisms. Various studies have proven that hands become contaminated after touching environmental surfaces, yet current terminal clean protocols are often insufficient for stopping the spread of infection. For example, a 2008 study published in Infection Control and Epidemiology tested cleaning practices in 23 acute care hospitals. The study found that on average, less than half of the objects that were supposed to be disinfected during a terminal clean were actually addressed.
Electro-BioCide is a revolutionary class of disinfectant with a unique kill mechanism. During third-party testing at the ATS Labs in Eagan, Minn., Electro-BioCide exhibited a 6-log kill (99.9999 percent) during EPA protocol testing against the following organisms: MRSA, VRE, Pseudomonas aeruginosa, Staphylococcus aureus, Rhinovirus, Salmonella enteric, H1N1, HIV-1, and hepatitis A
In January 2009, Electro-BioCide underwent EPA-mandated live animal toxicity testing at Tox Monitor Labs in Chicago. Results from this testing confirmed that Electro-BioCide is a Category IV practically non toxic product. Category IV is the least toxic rating possible. With every ingredient used to produce Electro-BioCide being DfE (Designed for Environment) certified, Electro-BioCide is a radical departure from the toxic, hazardous chemical disinfectants currently used in healthcare facilities. To assure quality, Electro-BioCide is only sold as the key disinfectant in a service provided by certified bio-intervention specialists. It is not sold as a standalone product.
Bio-IS does not replace the environmental services staff. Instead, Bio-IS works with hospital leadership, infection control committees and environmental services to implement a next-generation bio-intervention process. When new infection situations arise, Bio-IS can quickly attack such situations before they become worse.
This is a new-to-the-world offering that can significantly improve the overall disinfection of a hospitals environmental surfaces, says Tom Boyer, CEO of Bio-Intervention Specialists. Our trained and certified teams deploy Electro-BioCide throughout patient care and other areas by using a state-of-art electronic spraying system. Our Bio-Intervention Service greatly minimizes the risk of human error and creates thorough coverage of hospital surfaces in a way that the spray bottle and rag simply cannot achieve. We accomplish a surgical style decontamination of hospital surfaces.
Besides having its own personnel available to be permanently positioned at, or to travel to, hospitals with infectious disease issues, Bio-IS has partnered with HSS Inc., a highly regarded hospital services company that will also have personnel available to be permanently positioned at, or travel to, hospitals experiences infection challenges. HSS is rated by Modern Healthcare as one of the leading providers of healthcare support services in the country.
With EPA registration now complete, by late November Bio-Intervention Specialists will have the ability to respond to emergent situations for many states across the country as it completes required state registration processes. Registration in most states not approved by November is expected in December, with the exception of a small number of states that have longer registration cycles.
For more information, visit http://www.bio-intervention.com.